Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

11:31 AM ET 8-K
Stock Buyback Butler National Corp BUKS

Butler National Announces $10M Stock Buyback

Butler National Corporation's Board of Directors authorized a $10 million increase to its existing stock repurchase program, bringing the total available authorization to approximately $11.9 million. The program was also extended through April 30, 2029, allowing for open market or privately negotiated transactions. Management intends to use the buyback as part of its capital allocation strategy to return value to shareholders based on market conditions.

Value
$10M
Term
through April 30, 2029
11:02 AM ET 8-K
Other 8-K Filing SDR Drone, Inc. SDCO

SDR Drone Other 8-K Filing

SDR Drone, Inc. disclosed the discovery of two historical administrative orders (from 2014 and 2018) issued against the company and its former CEO, Robert L. Cashman, for securities violations. The orders involve a Desist and Refrain Order from California and a Consent Order from South Carolina related to misrepresented stock sales. The company is disclosing these legacy regulatory issues as part of its assessment of their impact on a pending Regulation A offering.

Counterparty
California Commissioner of Business Oversight
10:28 AM ET 8-K
Loan & Debt VIP Play, Inc. VIPZ

VIP Play Debt Financing Update with Rick Hackel and The Access Fund I, LP

VIP Play, Inc. entered into amendments to extend the maturity dates of $450,000 in outstanding convertible promissory notes. The maturity for $300,000 in notes held by Rick Hackel was extended to February 28, 2027, while the $150,000 note held by The Access Fund I, LP was extended to August 31, 2027.

Counterparty
Rick Hackel and The Access Fund I, LP
Term
through Aug 2027
10:08 AM ET Form 4
Insider Selling Star Bulk Carriers Corp. SBLK

Star Bulk Carriers Insider Koert Erhardt Sells $182K of Stock

Koert Erhardt sold 6,000 shares of Star Bulk Carriers Corp. at $30.39 a share, worth $182K in total on Oct 5, 2026. Shares held after the trade: 10,080 (-37.3%).

Value
$182K
Shares
6,000
Price
$30.39
Holding change
-37.3%
Trade date
Oct 5, 2026
9:24 AM ET 8-K
Other 8-K Filing Cadrenal Therapeutics, Inc. CVKD

Cadrenal Therapeutics Other 8-K Filing

Cadrenal Therapeutics has initiated a formal strategic process to evaluate opportunities to maximize shareholder value, including potential licensing, asset sales, partnerships, or business combinations. The company has engaged Tungsten Advisors as its exclusive financial advisor following alignment with the FDA on a Phase 3 pathway for its lead asset, CAD-1005.

Counterparty
Tungsten Advisors
9:07 AM ET 8-K
Clinical Trial Data Pulse Biosciences, Inc. PLSE

Pulse Biosciences Clinical Trial Data

Pulse Biosciences reached its enrollment target of 164 evaluable patients in the NANOPULSE-AF IDE pivotal clinical study three months ahead of schedule. The study evaluates the safety and effectiveness of the nPulse Cardiac Catheter System for treating drug-resistant paroxysmal atrial fibrillation. Primary safety and effectiveness endpoints will be assessed at 6 and 12 months post-ablation to support future regulatory submissions.

9:05 AM ET 8-K
Stock Buyback Coffee Holding Co Inc JVA

Coffee Holding Co Announces $2.5M Stock Buyback

Coffee Holding Co., Inc. announced that its Board of Directors has authorized a new share repurchase program to buy back up to $2.5 million of its common stock. The company plans to fund the repurchases using available cash and future cash flow from operations, citing a belief that the current stock price does not reflect the company's underlying fundamentals.

Value
$2.5M
9:04 AM ET 8-K
Leadership Change Alkami Technology, Inc. ALKT

Alkami Technology Leadership Change

Prerna Sachdeva, Chief Accounting Officer and principal accounting officer, has resigned effective November 2, 2026, to pursue other opportunities. CFO Cassandra Hudson will assume the role of principal accounting officer on an interim basis starting November 3, 2026, while the company searches for a permanent replacement.

9:01 AM ET 8-K
Licensing Deal BioNexus Gene Lab Corp BGLC

BioNexus Gene Lab Licensing Deal with Ruanyun Edai Technology Inc. Worth $3.5M

BioNexus Gene Lab Corp. entered into an exclusive 10-year licensing agreement with Ruanyun Edai Technology Inc. (RYET) for the CogniAI document-intelligence platform in the Malaysian healthcare sector. The company will issue 410,000 shares to satisfy the $3.5 million license consideration and an additional 150,000 shares in exchange for 500,000 RYET ordinary shares. BioNexus intends to use the platform to target Malaysia's RM1 billion public healthcare digitalization program.

Value
$3.5M
Counterparty
Ruanyun Edai Technology Inc.
Term
10 years
9:00 AM ET 8-K
Nasdaq/NYSE Compliance Notice Onfolio Holdings, Inc ONFO

Onfolio Holdings Nasdaq/NYSE Compliance Notice

Onfolio Holdings received an extension from Nasdaq until November 23, 2026, to regain compliance with the $2.5 million minimum stockholders' equity requirement. The company originally received a deficiency notice in May 2026 and must now evidence compliance by the new deadline to avoid potential delisting. The extension has no immediate effect on the trading of the company's common stock (ONFO) or warrants (ONFOW).

Counterparty
Nasdaq
Term
until Nov 23, 2026
9:00 AM ET 8-K/A
Other 8-K Filing Modine Manufacturing Co MOD

Modine Manufacturing Other 8-K Filing

Modine Manufacturing Company completed the spin-off of its Performance Technologies business and its subsequent combination with Gentherm Incorporated via a Reverse Morris Trust transaction. This filing provides the required unaudited pro forma financial information showing the impact of the divestiture on Modine's balance sheet and operations, treating the business as discontinued operations.

Counterparty
Gentherm Incorporated
9:00 AM ET 8-K
Divestiture Ultragenyx Pharmaceutical Inc. RARE

Ultragenyx Pharmaceutical Divestiture for $210M

Ultragenyx Pharmaceutical Inc. entered into an asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $210 million in cash. The PRV was recently awarded by the FDA following the approval of GENGLYCOS for the treatment of glycogen storage disease type Ia. Under a prior agreement, the company will pay 20% of the gross proceeds from this sale to the NIH.

Value
$210M
9:00 AM ET 8-K
Clinical Trial Data BioCardia, Inc. BCDA

BioCardia Clinical Trial Data

BioCardia announced it will present the trial design and scientific support for its CardiAMP HF II Study at the Heart Failure Society of America Annual Scientific Meeting. The study evaluates a high-dose autologous cell treatment for patients with ischemic heart failure of reduced ejection fraction (HFrEF) who remain symptomatic despite medical therapy.

Counterparty
Heart Failure Society of America
9:00 AM ET Form 4
Insider Selling Aflac Inc AFL

Aflac Insider Japan Post Holdings Co. Ltd. Sells $1.46M of Stock

Japan Post Holdings Co. Ltd. sold 13,000 shares of Aflac Inc at $112.25 a share, worth $1.46M in total on Oct 5, 2026. Shares held after the trade: 50,407,190 (-0.0%).

Value
$1.46M
Shares
13,000
Price
$112.25
Holding change
-0.0%
Trade date
Oct 5, 2026
9:00 AM ET 8-K
Court & Legal Update Envoy Medical, Inc. COCH

Envoy Medical Court & Legal Update

Envoy Medical entered into a Dismissal Agreement with Atlas Merchant Capital SPAC Fund I LP to resolve litigation in the Delaware Court of Chancery. The litigation concerned allegations that Atlas was not permitted to redeem its shares during the company's September 2023 business combination. All claims will be dismissed with prejudice with no payment required from Envoy Medical or other defendants.

Counterparty
Atlas Merchant Capital SPAC Fund I LP
8:57 AM ET Form 4
Insider Buying AgomAb Therapeutics NV AGMB

AgomAb Therapeutics Insider David R. Epstein Buys $86.3K of Stock

David R. Epstein bought 10,000 shares of AgomAb Therapeutics NV at $8.57 to $8.70 a share (average $8.63) in 2 transactions, worth $86.3K in total between Oct 5, 2026 and Oct 6, 2026. Shares held after the trade: 10,000 (+100.0%).

Value
$86.3K
Shares
10,000
Average price
$8.63
Holding change
+100.0%
Trade date
Oct 5, 2026 to Oct 6, 2026
8:56 AM ET 8-K
Shareholder Meeting Neogen Corp NEOG

Neogen Shareholder Meeting

Neogen Corporation held its 2026 Annual Meeting of Shareholders on October 1, 2026, where shareholders elected three directors and ratified BDO USA, P.C. as the independent auditor for fiscal 2027. Shareholders also approved an advisory vote on executive compensation and authorized amendments to both the Omnibus Incentive Plan and the Employee Stock Purchase Plan, including an increase in shares available for issuance.

8:48 AM ET 8-K
Investor Presentation Bitmine Immersion Technologies, Inc. BMNR

Bitmine Immersion Technologies Investor Presentation

Bitmine Immersion Technologies published an investor presentation and video transcript delivered by Executive Chairman Tom Lee at the Token2049 Global Conference in Singapore. The filing includes the formal presentation deck and a press release announcing the event under Item 7.01.

Counterparty
Token2049 Global Conference
8:47 AM ET Form 4
Insider Buying AgomAb Therapeutics NV AGMB

AgomAb Therapeutics CFO Pierre Thadee Victor Kemula Buys $85.9K of Stock

Pierre Thadee Victor Kemula, CFO, bought 10,000 shares of AgomAb Therapeutics NV at $8.54 to $8.67 a share (average $8.59) in 3 transactions, worth $85.9K in total on Oct 6, 2026. Shares held after the trade: 10,000 (+25.0%).

Value
$85.9K
Shares
10,000
Average price
$8.59
Role
CFO
Holding change
+25.0%
Trade date
Oct 6, 2026
8:39 AM ET 8-K
Business Update AIB Data Centers Inc. AIB

AIB Data Centers Business Update

AIB Data Centers issued a CEO letter highlighting the execution of a 12-year, 50 MW agreement with Nebius for its CLT1 data center campus. The company also completed a strategic acquisition in Texas, increasing its total contracted utility power capacity from 65 MW to 120 MW. Management stated that development of CLT1 will be funded through customer prepayments and project-level financing rather than corporate-level common equity.

Counterparty
Nebius
Term
12 years
8:37 AM ET 8-K
Dividend Ellington Financial Inc. EFC

Ellington Financial Dividend

Ellington Financial Inc. announced that its Board of Directors has declared a monthly dividend of $0.13 per share of common stock. The dividend is payable on November 30, 2026, to stockholders of record as of the close of business on October 30, 2026.

8:36 AM ET 8-K
Dividend Ellington Credit Co EARN

Ellington Credit Dividend

Ellington Credit Company's Board of Trustees declared a monthly common distribution of $0.08 per share. The dividend is payable on November 30, 2026, to shareholders of record as of October 30, 2026.

8:35 AM ET 8-K
Business Update TaoWeave, Inc. TWAV

TaoWeave Business Update

TaoWeave's portfolio company, Manako Labs Ltd., has commercially launched its Physical AI Vision Agents across 124 unmanned Avia Xpress fuel stations in France. Avia Thévenin-Ducrot has named Manako its lead Physical AI design partner to monitor equipment failures and site security using existing camera infrastructure. TaoWeave holds North American commercialization rights to the platform and participates in revenue generated through licensing agreements.

Counterparty
Avia Thévenin-Ducrot
8:33 AM ET 8-K
Shareholder Meeting Launch Two Acquisition Corp. LPBB

Launch Two Acquisition Shareholder Meeting

Launch Two Acquisition Corp. has further postponed its extraordinary general meeting of shareholders from October 7, 2026, to October 8, 2026. The meeting's primary purpose is to vote on an extension amendment proposal to move the company's business combination deadline from October 9, 2026, to as late as April 9, 2027.

8:30 AM ET 8-K
Divestiture Cero Therapeutics Holdings, Inc. CERO

Cero Therapeutics Holdings Divestiture to SRX Global Inc. for $10.8M

CERo Therapeutics Holdings, Inc. entered into a definitive agreement to sell its wholly owned operating subsidiary, CERo Therapeutics, Inc., to SRX Global Inc. The consideration includes $1 million in SRX common stock, the assumption of approximately $1.562 million in liabilities, and the forgiveness of a senior secured promissory note with an outstanding balance of approximately $8.25 million. The agreement includes a 30-day 'go-shop' period allowing the company to solicit superior proposals.

Value
$10.8M
Counterparty
SRX Global Inc.
8:30 AM ET 8-K
M&A Deal Charlton Aria Acquisition Corp CHAR

Charlton Aria Acquisition Signs $80M M&A Deal with KQC Quantum, Inc.

Charlton Aria Acquisition Corporation (Nasdaq: CHAR) has entered into a definitive business combination agreement with KQC Quantum, Inc., a South Korean enterprise quantum computing and security company. The transaction values KQC at a pre-money equity value of $80 million, with the combined company expected to list on Nasdaq in the first half of 2027. KQC shareholders will roll 100% of their equity into the new entity, which will focus on commercializing its AI-driven hybrid quantum platform, Qubiteer.

Value
$80M
Counterparty
KQC Quantum, Inc.
8:25 AM ET 8-K
Partnership OpenWorld, Inc. OPNW

OpenWorld Partnership with Beyond Limits, Inc. Worth $130M

OpenWorld, Inc. entered into a non-binding term sheet with Beyond Limits, Inc. (BeyondAI) and Eidos Digital Assets SPC for a proposed $130 million intellectual property-backed financing transaction. OpenWorld will provide the tokenization platform, technology integration, and operational services to structure digital tokens backed by BeyondAI's patents and software rights.

Value
$130M
Counterparty
Beyond Limits, Inc. (BeyondAI)
8:24 AM ET 8-K
Business Update Mexico Fund Inc MXF

Mexico Fund Business Update

The Mexico Fund, Inc. released its monthly summary report for September 2026, disclosing total net assets of $329.90 million and a Net Asset Value (NAV) per share of $22.88. The report provides a snapshot of the fund's top ten holdings, which represent 68.06% of net assets, and notes that no shares were repurchased during the month.

Term
September 2026
8:11 AM ET 8-K
Leadership Change Fuelcell Energy Inc FCEL

Fuelcell Energy Leadership Change

Michael S. Bishop will step down as Executive Vice President, CFO, and Treasurer of FuelCell Energy effective October 6, 2026. He will transition to a Senior Advisor role through April 6, 2027, receiving an annualized base salary of $461,591 and subsequent severance benefits including 12 months of salary and accelerated equity vesting.

Term
6 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.